Privacy & Data Security

FDA recently announced that it will host a public workshop on August 6, 2024 focused on “Artificial Intelligence (AI) in Drug & Biological Product Development.”  Aimed at bringing drug sponsors and AI experts together, the workshop, hosted in collaboration with the Clinical Trials Transformation Initiative, will feature presentations and a panel discussion around guiding principles

@media screen and (max-width: 1023px){section[data-id=”block_211bf465a1eb064f36a44727b27856a5″]{ }}@media screen and (min-width: 1024px) and (max-width: 1365px){section[data-id=”block_211bf465a1eb064f36a44727b27856a5″]{ }}@media screen and (min-width: 1366px){section[data-id=”block_211bf465a1eb064f36a44727b27856a5″]{ }}